SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
902 9 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
177I would say they've done a very decent job of surviving the tragic circumstaThe Ox-10/16/2013
176Neptune 2nd Quarter Conference Call – Are The Stars Aligning? howardgroupinsigSultan-10/16/2013
175Neptune Reports Second Quarter Results and Provides Update on Action Plan to ResSultan-10/15/2013
174Right.. I see the the royalty agreement in their favour as a big hurdle they hSultan-10/3/2013
173The stock has been acting well....since the August dip <img src='http://The Ox-10/3/2013
172Thursday, 3 October 2013 EuroPac Analyst Doug Loe’s Perspective on Neptune’s SSultan-10/3/2013
171Patent Infringement Settlements Reached Neptune Grants a Royalty Bearing LicensSultan-10/2/2013
170Fund Manager Hugh Cleland Comments On Recent Neptune & Acasti Stock VolatiliSultan-9/9/2013
169Thursday, September 5, 2013 Alex Ruus on BNN: We Think Sultan19/5/2013
168JMP Securities Increases Neptune Price Target To $7 [graphic] Neptune TecSultan-8/16/2013
167Thursday, August 15, 2013 Catalyst Equity Research BoosSultan-8/15/2013
166Neptune & Acasti Target Prices Increased By Euro Pacific Canada Analyst NeSultan-8/14/2013
165They are going to be moving to Ph III and it will be done in US .. It mentions tSultan-8/13/2013
164Sultan, Have they (Acasti) got a phase III trial in the pipeline? I sold a dMark Bartlett-8/13/2013
163H.C. Wainwright & Co. Initiates Coverage On Neptune - $9 Target [graphic] Sultan18/13/2013
162Acasti Announces Positive Phase II Open Label Clinical Trial Results Laval, Qu&Sultan-8/13/2013
161Well Known U.S. Investor Acquires Over 10% Of Neptune howardgroupinsightnewsletSultan-7/17/2013
160Acquisition of Securities of Neptune Technologies & Bioressources Inc. WASHSultan-7/17/2013
159Neptune Awarded Canadian Patent & Conference Call Highlights howardgroupinsSultan17/16/2013
158Neptune Awarded Canadian Composition of Matter Patent LAVAL, Quebec, July 16, 2Sultan-7/16/2013
157Neptune Reports First Quarter Results and Provides Update on Action Plan to ResuSultan17/15/2013
156Neptune Announces Issuance of Shares Under Previously Announced Royalty PrepaymSultan-7/13/2013
155Hugh Cleland - Acasti “May In Fact Be In Possession Of A Blockbuster” & ConfSultan17/9/2013
154Neptune to Present at JMP Securities Healthcare Conference LAVAL, Quebec, July Sultan17/3/2013
153Acasti Reports Results of Annual and Special Meeting finance.yahoo.comSultan-6/29/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):